Publications list for Dr Markus Hofer

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009


  • Visekruna, A., Linnerz, T., Martinic, V., Vachharajani, N., Hartmann, S., Harb, H., Joeris, T., Pfefferle, P., Hofer, M., Steinhoff, U. (2015), Transcription factor c-Rel plays a crucial role in driving anti-CD40-mediated innate colitis. Mucosal Immunology. 8(2), 307-315. [Abstract]


  • Teymoortash, A., Zieger, L., Hoch, S., Pagenstecher, A., Hofer, M. (2014), Distinct microscopic features of perineural invasion in adenoid cystic carcinoma of the head and neck. Histopathology. , 1037-1039. [Abstract]
  • Li, W., Hofer, M., Jung, S., Lim, S., Campbell, I. (2014), IRF7-DEPENDENT, TYPE I INTERFERON PRODUCTION INDUCES LETHAL IMMUNE-MEDIATED DISEASE IN STAT1 KO MICE INFECTED WITH LCMV. Journal of Virology. 88(13), 7578. [Abstract]
  • Noçon, A., Ip, J., Terry, R., Lim, S., Getts, D., Mülller, M., Hofer, M., King, N., Campbell, I. (2014), The bacteriostatic protein lipocalin 2 is induced in the central nervous system of mice with west Nile virus encephalitis. Journal of Virology. 88(1), 679-689. [Abstract]


  • Siegfried, A., Berchtold, S., Manncke, B., Deuschle, E., Reber, J., Ott, T., Weber, M., Kalinke, U., Hofer, M., Hatesuer, B., Schughart, K., Gailus-Durner, V., Fuchs, H., Hrabe de Angelis, M., Weber, F., Hornef, M., Autenrieth, I., Bohn, E. (2013), IFIT2 Is an Effector Protein of Type I IFN-Mediated Amplification of Lipopolysaccharide (LPS)-Induced TNF-alpha Secretion and LPS-Induced Endotoxin Shock. Journal of Immunology. 191(7), 3913-3921. [Abstract]
  • Li, W., Hofer, M., Noçon, A., Manders, P., Campbell, I. (2013), Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice. Virology. 439(2), 152-162. [Abstract]
  • Hofer, M., Campbell, I. (2013), Type I interferon in neurological disease-The devil from within. Cytokine & Growth Factor Reviews. 24(3), 257-267. [Abstract]
  • Zimmermann, J., Krauthausen, M., Hofer, M., Heneka, M., Campbell, I., Müller, M. (2013), CNS-Targeted Production of IL-17A Induces Glial Activation, Microvascular Pathology and Enhances the Neuroinflammatory Response to Systemic Endotoxemia. PloS One. 8(2), e57307. [Abstract]


  • Getts, D., Terry, R., Getts, M., Müller, M., Rana, S., Deffrasnes, C., Ashhurst, T., Radford, J., Hofer, M., Thomas, S., Campbell, I., King, N. (2012), Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. Journal of Neuroinflammation. 9(1), 246. [Abstract]
  • Hofer, M., Riehmer, V., Kuhnt, D., Braun, V., Nimsky, C., Weber, R., Sommer, C., Pagenstecher, A. (2012), Genomic profiling to assess the clonal relationship between histologically distinct intracranial tumours. Neuropathology and Applied Neurobiology. 38(5), 500-504. [Abstract]
  • Hofer, M., Li, W., Manders, P., Terry, R., Lim, S., King, N., Campbell, I. (2012), Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. Journal of Virology. 86(12), 6932-6946. [Abstract]


  • Ip, J., Noçon, A., Hofer, M., Lim, S., Müller, M., Campbell, I. (2011), Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. Journal of Neuroinflammation. 8, 124. [Abstract]


  • Campbell, I., Hofer, M., Pagenstecher, A. (2010), Transgenic models for cytokine-induced neurological disease. Biochimica et biophysica acta. 1802(10), 903-17. [Abstract]
  • Müller, M., Carter, S., Hofer, M., Campbell, I. (2010), The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum. Neuropathology and applied neurobiology. 36(5), 368-87. [Abstract]
  • Ellis, S., Gysbers, V., Manders, P., Li, W., Hofer, M., Müller, M., Campbell, I. (2010), The Cell-Specific Induction of CXC Chemokine Ligand 9 Mediated by IFN-{gamma} in Microglia of the Central Nervous System Is Determined by the Myeloid Transcription Factor PU.1. Journal of immunology (Baltimore, Md. : 1950). 185(3), 1864-77. [Abstract]
  • Hofer, M., Li, W., Lim, S., Campbell, I. (2010), The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. The Journal of neuroscience : the official journal of the Society for Neuroscience. 30(3), 1149-1157. [Abstract]
  • Thompson, C., Hofer, M., Campbell, I., Holmes, A. (2010), Community dynamics in the mouse gut microbiota: a possible role for IRF9-regulated genes in community homeostasis. PLoS One. 5(4), e10335. [Abstract]


  • Quintana, A., Müller, M., Frausto, R., Ramos, R., Getts, D., Sanz, E., Hofer, M., Krauthausen, M., King, N., Hidalgo, J., Campbell, I. (2009), Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. Journal of Immunology. 183(3), 2079-2088. [Abstract]
  • Vetter, M., Hofer, M., Roth, E., Pircher, H., Pagenstecher, A. (2009), Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma. Journal of Neuropathology and Experimental Neurology. 68(5), 525-534. [Abstract]